Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.
D000818:Animals; D000917:Antibody Formation; D001500:BCG Vaccine / Q000627:therapeutic use*; D003168:Complement Fixation Tests; D005354:Fibrosarcoma / Q000628:therapy*; D006168:Guinea Pigs; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy; D008545:Melanoma / Q000628:therapy*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D012516:Osteosarcoma / Q000628:therapy*; D012208:Rhabdomyosarcoma / Q000628:therapy*; D012513:Sarcoma, Experimental / Q000628:therapy
D001500:BCG Vaccine